ENDONOVO THERAPEUTICS, INC. Quarterly Return On Equity in % from Q3 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Endonovo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2012 to Q3 2023.
  • Endonovo Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was 17.3 %, a 0.35% decline year-over-year.
  • Endonovo Therapeutics, Inc. annual Return On Equity for 2022 was 83.1 %, a 348% increase from 2021.
  • Endonovo Therapeutics, Inc. annual Return On Equity for 2021 was 18.6 %, a 491% increase from 2020.
  • Endonovo Therapeutics, Inc. annual Return On Equity for 2020 was 3.14 %, a 97.1% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 17.3 -0.06 -0.35% Jul 1, 2023 Sep 30, 2023
Q2 2023 17.2 -5.64 -24.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 37.1 +20.6 +125% Jan 1, 2023 Mar 31, 2023
Q4 2022 83.1 +64.5 +348% Oct 1, 2022 Dec 31, 2022
Q3 2022 17.3 -28.6 -62.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 22.9 -24.3 -51.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 16.4 -37.2 -69.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 18.6 +15.4 +491% Oct 1, 2021 Dec 31, 2021
Q3 2021 46 +17.5 +61.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 47.1 +18.2 +62.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 53.6 -12 -18.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 3.14 -104 -97.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 28.5 -45.1 -61.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 28.9 -82.1 -74% Apr 1, 2020 Jun 30, 2020
Q1 2020 65.6 -5.58 -7.84% Jan 1, 2020 Mar 31, 2020
Q4 2019 107 +47.1 +79% Oct 1, 2019 Dec 31, 2019
Q3 2019 73.6 +15.1 +25.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 111 +44.1 +65.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 71.2 +35 +96.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 59.6 -36.6 -38.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 58.5 -62.7 -51.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 66.9 -23.3 -25.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 36.2 -94.1 -72.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 96.2 +32.4 +50.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 121 +15.2 +14.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 90.2 -12.5 -12.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 130 +33.2 +34.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 63.8 -42.6 -40% Oct 1, 2016 Dec 31, 2016
Q3 2016 106 +57.2 +117% Jul 1, 2016 Sep 30, 2016
Q2 2016 103 Apr 1, 2016 Jun 30, 2016
Q1 2016 97.1 Jan 1, 2016 Mar 31, 2016
Q4 2015 106 Oct 1, 2015 Dec 31, 2015
Q3 2015 48.7 Jul 1, 2015 Sep 30, 2015
Q4 2013 89 -45.3 -33.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 102 -90.2 -47% Jul 1, 2013 Sep 30, 2013
Q2 2013 122 Apr 1, 2013 Jun 30, 2013
Q1 2013 142 Jan 1, 2013 Mar 31, 2013
Q4 2012 134 Oct 1, 2012 Dec 31, 2012
Q3 2012 192 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.